Skip to main content
. 2023 Jul 19;129(5):852–860. doi: 10.1038/s41416-023-02352-5

Table 2.

Systemic treatments received prior to palbociclib initiation.

Overall population (n = 191)
Chemotherapy
  Number of lines of prior chemotherapy for metastatic disease, median (range) (n = 29) 1.0 (1.0–3.0)
 Patients treated with neoadjuvant chemotherapy, n (%)
   Yes 23 (12%)
   No 168 (88%)
 Patients treated with adjuvant chemotherapy, n (%)
   Yes 67 (35%)
   No 124 (65%)
 Chemotherapy for advanced/metastatic, n (%)
   Yes 29 (15%)
   No 162 (85%)
Hormone therapy
  Number of lines of prior hormone therapy for metastatic disease, median (range) (n = 74) 1.0 (1.0-4.0)
 Neoadjuvant hormone therapy, n (%)
   Yes 7 (4%)
   No 184 (96%)
 Adjuvant hormone therapy, n (%)
   Yes 110 (58%)
   No 81 (42%)
 Hormone therapy for advanced/metastatic, n (%)
   Yesa 73 (38%)
   No 118 (62%)
 Type of hormone therapy, n (%)
   Neoadjuvant
     Anastrozole/letrozole 4 (2%)
     Tamoxifen 3 (2%)
  Adjuvant
    Anastrozole/letrozole 33 (17%)
    Exemestane 11 (6%)
    Tamoxifen 84 (44%)
    Goserelin only 2 (1%)
    Goserelin with Anastrozole 1 (1%)
    Goserelin with Letrozole 1 (1%)
    Goserelin with Tamoxifen, then Exemestane 1 (1%)
  Metastatic setting
    Anastrozole/letrozole 46 (24%)
    Exemestane 12 (6%)
    Fulvestrant 3 (2%)
    Tamoxifen 12 (6%)
    Goserelin only 2 (1%)
    Goserelin with letrozole 9 (5%)
    Goserelin with exemestane, letrozole and tamoxifen 1 (1%)

aIncludes any patient, regardless of treatment line, with at least one hormone therapy recorded as being in the advanced/disease modifying/metastatic setting. Standard imputation of data was required for the date chemotherapy was started (27 instances [19 instances with only year recorded, 8 instances with only month and year recorded]) and stopped (28 instances [11 instances with only year recorded, 17 instances with only month and year recorded]); hormone therapy was started (65 instances [33 instances with only year recorded, 32 instances with only month and year recorded]) and stopped (73 instances [34 instances with only year recorded, 39 instances with only month and year recorded]).